| |
| Issue |
Title |
| |
| Vol 26, No 1 (2026) |
Long-term stability of liposomal mycobacteriophage D29: A comprehensive in vitro assessment |
Abstract
PDF (Rus)
|
|
V. V. Avdeev, M. B. Lapenkova, M. A. Vladimirsky |
| |
| Vol 26, No 1 (2026) |
Production and functional activity of scFv fragments obtained from recombinant antibodies against influenza virus |
Abstract
PDF (Rus)
|
|
M. A. Plotnikova, V. A. Toporova, E. A. Romanovskaya-Romanko, A. A. Shaldzhyan, S. A. Klotchenko |
| |
| Vol 26, No 1 (2026) |
Effect of primer binding sites mutations on the efficacy of measles virus RNA detection using PCR and LAMP techniques |
Abstract
PDF (Rus)
|
|
G. M. Tsyganova, E. D. Bogoslovskaya, G. A. Shipulin, O. Yu. Shipulina, E. V. Bogoslovskaya |
| |
| Vol 26, No 1 (2026) |
Validation of an in vitro biological method for filgrastim potency assessment |
Abstract
PDF (Rus)
|
|
L. A. Gaiderova, M. L. Baykova, O. V. Golovinskaya, S. L. Lysikova, V. V. Fomenko, N. A. Alpatova |
| |
| Vol 26, No 1 (2026) |
Chikungunya virus-specific pre-existing T cell responses in naïve donors and B cell epitopes in seropositive individuals and experimentally infected mice |
Abstract
PDF (Eng)
|
|
A. A. Nikonova, A. S. Poroshina, T. G. Samartseva, A. G. Samartseva, A. G. Adelfinskaya, B. Tahhan, N. N. Shershakova, M. R. Khaitov, A. S. Oksanich, G. M. Ignatyev, V. V. Zverev |
| |
| Vol 26, No 1 (2026) |
Human plasma in the production of medicinal products: national differences in terms of harmonization with global compendial requirements |
Abstract
PDF (Rus)
|
|
О. A. Demidova, O. G. Kornilova, O. V. Muslimova, V. L. Bagirova |
| |
| Vol 26, No 1 (2026) |
Anniversary metrics of the journal: a 25-year history in statistics and facts |
Abstract
PDF (Rus)
|
|
Article Editorial |
| |
| Vol 26, No 1 (2026) |
To the 25th anniversary of the journal Biological Products. Prevention, Diagnosis, Treatment |
Abstract
PDF (Rus)
|
|
A. S. Korovkin, O. F. Fedotova, O. Yu. Goykalova |
| |
| Vol 26, No 1 (2026) |
“My work is grounded in the principles of evidence-based medicine” |
Abstract
PDF (Rus)
|
|
V. A. Merkulov |
| |
| Vol 26, No 1 (2026) |
Two-component vector-based vaccine Ad26.ZEBOV, MVA-BN-Filo against Ebola fever: A review of clinical studies |
Abstract
PDF (Rus)
|
|
L. F. Stovba, O. V. Chukhralya, D. I. Paveliev, M. I. Soldatenkova, D. P. Belozerov, A. A. Petrov, S. V. Borisevich |
| |
| Vol 26, No 1 (2026) |
Specific activity and toxicity of lyophilized recombinant human granulocyte-macrophage colony-stimulating factor (E. coli BL21/pET-GST6His-GM): in vitro and in vivo study |
Abstract
PDF (Rus)
|
|
S. G. Gamaley, G. G. Shimina, E. A. Vyazovaya, O. V. Simakova, T. G. Yadrenkina, O. S. Taranov, V. V. Omigov, K. F. Emtsova, T. I. Esina, E. A. Volosnikova, E. D. Danilenko |
| |
| Vol 26, No 1 (2026) |
Standardizing microbiological method to detect mycoplasma contamination in biological products: development of Acholeplasma laidlawii PG8 reference standard |
Abstract
PDF (Rus)
|
|
S. M. Sukhanova, Z. E. Berdnikova, O. V. Fadeikina |
| |
| 1 - 12 of 12 Items |
|
